Literature DB >> 15703785

e8a2 BCR-ABL: more frequent than other atypical BCR-ABL variants?

S Demehri, P Paschka, B Schultheis, T Lange, T Koizumi, T Sugimoto, S Branford, L C Lim, T Kegel, G Martinelli, A Hochhaus, B J Druker, M W N Deininger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15703785     DOI： 10.1038/sj.leu.2403604

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  9 in total

1.  Major molecular response to imatinib in a patient with chronic myeloid leukemia expressing a novel form of e8a2 BCR-ABL transcript.

Authors:  A Tchirkov; J-L Couderc; B Périssel; C Goumy; A Regnier; N Uhrhammer; P Verrelle; M Berger
Journal:  Leukemia       Date:  2006-01       Impact factor: 11.528

Review 2.  ABL tyrosine kinases: evolution of function, regulation, and specificity.

Authors:  John Colicelli
Journal:  Sci Signal       Date:  2010-09-14       Impact factor: 8.192

3.  A Novel e8a2BCR-ABL1 Fusion Transcript without Insertion Sequence in a Patient with Chronic Myeloid Leukemia.

Authors:  Caibao Jin; Xiaojian Zhu; Min Xiao; Songya Liu; Xian Liu; Jingjing Liu; Xiuwen Xu; Shujuan Yi; Li Meng
Journal:  Ann Lab Med       Date:  2018-03       Impact factor: 3.464

4.  Novel BCR-ABL1 fusion and leukemic mutations of SETBP1, PAX5, and TP53 detected by next generation sequencing in chronic myeloid leukemia.

Authors:  Shuang Fu; Yanping Hu; Yu Fu; Fang Chen; Xuan Liu; Minyu Zhang; Xiaohui Wang; Shichun Tu; Jihong Zhang
Journal:  Cancer Biol Ther       Date:  2016-09-10       Impact factor: 4.742

Review 5.  Chronic Myeloid Leukemia: Modern therapies, current challenges and future directions.

Authors:  Afaf E G Osman; Michael W Deininger
Journal:  Blood Rev       Date:  2021-03-16       Impact factor: 10.626

6.  A novel BCR-ABL1 fusion gene identified by next-generation sequencing in chronic myeloid leukemia.

Authors:  Xiaodong Lyu; Jingke Yang; Xianwei Wang; Jieying Hu; Bing Liu; Yu Zhao; Zhen Guo; Bingshan Liu; Ruihua Fan; Yongping Song
Journal:  Mol Cytogenet       Date:  2016-06-27       Impact factor: 2.009

Review 7.  Molecular techniques for the personalised management of patients with chronic myeloid leukaemia.

Authors:  Mary Alikian; Robert Peter Gale; Jane F Apperley; Letizia Foroni
Journal:  Biomol Detect Quantif       Date:  2017-02-14

Review 8.  Fusion transcripts: Unexploited vulnerabilities in cancer?

Authors:  Carla Neckles; Soumya Sundara Rajan; Natasha J Caplen
Journal:  Wiley Interdiscip Rev RNA       Date:  2019-08-13       Impact factor: 9.957

9.  A case report of pediatric acute lymphoblastic leukemia with e8a2 BCR/ABL1 fusion transcript.

Authors:  Aleksandra Mroczkowska; Bożena Jaźwiec; Justyna Urbańska-Rakus; Sylwia Szymanowska; Anna Tessmann; Sonia Pająk; Katarzyna Machnik; Olga Haus; Tomasz Wróbel
Journal:  BMC Med Genomics       Date:  2022-02-05       Impact factor: 3.063
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.